Role of dopamine in behavioral effects of serotonin microinjected into rat striatum

Pharmacology Biochemistry and Behavior

Volumn 56, Issue 2, 1997, Pages 251-259

  Yeghiayan, S K ^a,b,d   Kelley, A E ^c   Kula, N S ^a,b   Campbell, A ^a,b   Baldessarini, R J ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d MCLEAN HOSPITAL   (United States)

Author keywords

5 hydroxytryptamine; behavior; dopamine; indoleamines; serotonin; stereotyp y; striatum; transport; tyramine; uptake

Indexed keywords

5 HYDROXYTRYPTOPHAN; INDOLEAMINE; NOMIFENSINE; OXIDOPAMINE; SEROTONIN; TRYPTAMINE; TYRAMINE; VANOXERINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN PERFUSION; BRAIN SYNAPTOSOME; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE UPTAKE; DOPAMINERGIC SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOTYPY;

ANIMALS; BIOLOGICAL TRANSPORT; CORPUS STRIATUM; DOPAMINE; INDOLES; MALE; MICROINJECTIONS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; STEREOTYPED BEHAVIOR; STRUCTURE-ACTIVITY RELATIONSHIP; SYNAPTOSOMES; TYRAMINE;

EID: 0031044591     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00217-1     Document Type: Article

References (71)

1. Andrews, D. W.; Patrick, R. L.; Barchas, J. D. The effects of 5-hydroxytryptophan and 5-hydroxytryptamine on dopamine synthesis and release in rat brain striatal synaptosomes. J. Neurochem. 30:465-470; 1978.
2. Arbuthnott, G. W.; Fairbrother, I. S.; Butcher, S. P. Dopamine release and metabolism in the rat striatum: An analysis by 'in vivo' brain microdialysis. Pharmacol. Ther. 48:281-293; 1990.
3. Baldessarini, R. J.; Amatruda III, T. T.; Griffith, F. F.; Gerson, S. Differential effects of serotonin on turning and stereotypy induced by apomorphine, Brain Res. 93:158-163; 1975.
4. Baldessarini, R. J.; Marsh, E. R.; Kula, N. S. Interactions of fluoxetine with metabolism of dopamine and serotonin in rat brain regions. Brain Res. 579:152-156; 1992.
5. Baldessarini, R. J.; Vogt, M. The uptake and subcellular distribution of aromatic amines in the brain of the rat. J. Neurochem. 18:2519-2533; 1971.
6. 3H-dopamine and analogous monoamines from rat striatal tissue. Cell. Mol. Neurobiol. 8:205-216; 1988.
7. Beal, M. F.; Martin, J. B. Topographical dopamine and serotonin distribution and turnover in rat striatum. Brain Res. 358:10-15; 1985.
8. Benloucif, S.; Galloway, M. P. Facilitation of dopamine release in vivo by serotonin agonists: Studies with microdialysis. Eur. J. Pharmacol. 200:1-8; 1991.
9. Benloucif, S.; Keegan, M. J.; Galloway, M. P. Serotonin-facilitated dopamine release in vivo: Pharmacological characterization. J. Pharmacol. Exp. Ther. 265:373-377; 1993.
10. Benuck, M.; Reith, M. E. A. Dopamine releasing effect of phenylbiguanide in rat striatal slices. Naunyn-Schmiedeberg's Arch. Pharmacol. 345:666-672; 1992.
11. Bhat, R. V.; Baraban, J. M. Activation of transcription factor genes in striatum by cocaine: Role of both serotonin and dopamine systems. J. Pharmacol. Exp. Ther. 267:496-505; 1993.
12. 3 receptors in rat striatum. J. Pharmacol. Exp. Ther. 251:803-809; 1989.
13. Brus, R.; Kostrzewa, R. M.; Perry, K. W.; Fuller, R. W. Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment. J. Pharmacol. Exp. Ther. 268:231-237; 1994.
14. Carter, C. J.; Pycock, C. J. 5,7-Dihydroxytryptamine lesions in the amygdala reduce amphetamine- and apomorphine-induced stereotyped behaviour in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 312:235-238; 1980.
15. Carter, C. J.; Pycock, C. J. The role of 5-hydroxytryptamine in dopamine-dependent stereotyped behaviour. Neuropharmacology 20:261-265; 1981.
16. 3H]serotonin release in vitro induced by electrical stimulation in A9 and A10 dopamine regions of rat brain: Characterization and responsiveness to cocaine. J. Pharmacol. Exp. Ther. 267:379-389; 1993.
17. 3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res. 543:354-357; 1991.
18. Cousins, M. S.; Salamone, J. D. Nucleus accumbens dopamine depletions in rats affect relative response allocation in a novel cost/benefit procedure. Pharmacol. Biochem. Behav. 49:85-91; 1994.
19. Curzon, G. Stereotyped and other motor responses to 5-hydroxytryptamine receptor activation. In: Cooper, S. J.; Dourish, C. T., eds. Neurobiology of Stereotyped Behavior. Oxford: Clarendon Press; 1990:142-168.
20. 1 dopamine receptors in the rat brain: A quantitative autoradiographic analysis. J. Neurosci. 6:2352-2365; 1986.
21. de Belleroche, J. S.; Bradford, H. F. Presynaptic control of the synthesis and release of dopamine from striatal synaptosomes: A comparison between the effects of 5-hydroxy-tryptamine, acetylcholine, and glutamate. J. Neurochem. 35:1227-1234; 1980.
22. DeLean, A.; Munson, P. J.; Rodbard, D. Simultaneous analysis of families of sigmoid curves: Application to bioassay, radioligand, and physiological dose-response curves. Am. J. Physiol. 4:E97; 1978.
23. 1A agonist LY-165,163. Psychopharmacology 93:82-86; 1987.
24. Dumuis, A.; Bouhelal, R.; Sebben, M.; Cory, R.; Bockaert, J. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol. Pharmacol 34:880-887; 1988.
25. Ennis, C.; Kemp, J. D.; Cox, B. Characterisation of inhibitory 5-hydroxytryptamine receptors that modulate dopamine release in the striatum. J. Neurochem. 36:1515-1520; 1981.
26. Fairbrother, I. S.; Arbuthnott, G. W.; Kelly, J. S.; Butcher, S. P. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: I. Studies using veratrine and ouabain. J. Neurochem. 5:1834-1843; 1990.
27. Fischer, J. F.; Cho, A. K. Chemical release of dopamine from striatal homogenates: Evidence for an exchange diffusion model. J. Pharmacol. Exp. Ther. 208:203-209; 1979.
28. Floor, E.; Leventhal, P. S.; Wang, Y.; Meng, L.; Chen, W. Q. Dynamic storage of dopamine in rat brain synaptic vesicles in vitro. J. Neurochem. 64:689-699; 1995.
29. Fuller, R. W.; Snoddy, H. D.; Molloy, B. B. Central serotonin agonist actions of LY 165163, 1-(m-trifluoromethylphenyl)-4-(p-aminophenylethyl) piperazine, in rats. J. Pharmacol. Exp. Ther. 239:454-459; 1986.
30. 1B agonist CP-93,129 facilitates striatal dopamine release in vivo. Synapse 15:90-92; 1993.
31. Green, A. R.; Hall, J. E.; Rees, A. R. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists. Br. J. Pharmacol. 73:703-719; 1981.
32. Hitri, A.; Hurd, Y. L.; Wyatt, R. J.; Deutsch, S. I. Molecular, functional and biochemical characteristics of the dopamine transporter: Regional differences and clinical relevance. Clin. Neuropharmacol. 17:1-22; 1994.
33. Hurd, Y. L.; Ungerstedt, U. In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen. Eur. J. Pharmacol. 166:251-260; 1989.
34. 3H] dopamine via reversal of the dopamine transporter in rat striatum and nucleus accumbens: A comparison with release elicited by potassium, N-methyl-D-aspartic acid, glutamic acid and d-amphetamine. J. Pharmacol. Exp. Ther. 262:356-364; 1992.
35. 3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: An in vivo chronocoulometric study. Brain Res. 513: 156-160; 1990.
36. Jicha, G. A.; Salamone, J. D. Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: Possible relation to parkinsonian symptoms. J. Neurosci. 11:3822-3829; 1991.
37. Kelley, A. E.; Lang, C. G.; Gauthier, A. M. Induction of oral stereotypy following amphetamine microinjection into a discrete subregion of the striatum. Psychopharmacology 95:556-559; 1988.
38. Kelley, A. E.; Gauthier, A. M.; Lang, C. G. Amphetamine microinjections into distinct striatal subregions cause dissociable effects on motor and ingestive behavior. Behav. Brain Res. 35:27-39; 1989.
39. Lesch, K. P.; Bengel, D. Neurotransmitter reuptake mechanisms: Targets for drugs to study and treat psychiatric, neurological and neurodegenerative disorders. CNS Drugs 4:302-322; 1995.
40. Levi, G.; Raiteri, M. Carrier-mediated release of neurotransmitters. Trends Neurosci. 16:415-419; 1993.
41. Liang, N. Y.; Rutledge, C. O. Evidence for carrier-mediated efflux of dopamine from corpus striatum. Biochem. Pharmacol. 31:2479-2484; 1982.
42. Lucki, I.; Nobler, M. S.; Frazer, A. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat. J. Pharmacol. Exp. Ther. 228:133-139; 1984.
43. Meiergerd, S. M.; Schenk, J. O. Striatal transporter for dopamine: Catechol structure-activity studies and susceptibility to chemical modification. J. Neurochem. 62:998-1008; 1994.
44. 3H]dopamine by L-5-hydroxytryptophan. Brain Res. 45:499-505; 1972.
45. Nissbrandt, H.; Waters, N.; Hjorth, S. The influence of serotoninergic drugs on dopaminergic neurotransmission in rat substantia nigra, striatum and limbic forebrain in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol. 346:12-19; 1992.
46. 3H]dopamine from rat nucleus accumbens and striatal slices. Neurochem. Res. 13:403-407; 1988.
47. Parsons, L. H.; Justice, J. B. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res. 606:195-199; 1993.
48. Pellegrino, L. J.; Cushman, A. J. A stereotaxic atlas of the rat brain. Elliott, R. M.; Lindzey, G.; MacCorquodale, K., eds. New York: Appleton-Century-Crofts; 1967.
49. Raiteri, M.; Cerrito, F.; Cervoni, A. M.; Levi, G. Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J. Pharmacol. Exp. Ther. 208:195-202; 1979.
50. Rosenthal, R.; R. Rosnow, R. eds. Contrast analysis: Focused comparisons in the analysis of variance. New York: Cambridge Univ. Press; 1985.
51. Salamone, J. D.; Mahan, K.; Rogers, S. Ventrolateral striatal dopamine depletions impair feeding and food handling in rats. Pharmacol. Biochem. Behav. 44:605-610; 1993.
52. Schloss, P.; Mayser, W.; Betz, H. Neurotransmitter transporters: A novel family of integral plasma membrane proteins. Fed Eur Biochem Soc Lett 307(1):76-80; 1995.
53. 3H]dopamine. Eur. J. Pharmacol. 167:309-310; 1989.
54. Segal, M.; Weinstock, M. Differential effects of 5-hydroxytryptamine antagonists on behaviors resulting from activation of different pathways arising from the raphe nuclei. Psychopharmacology 79:72-78; 1983.
55. 2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J. Neurosci. 14:88-106; 1994.
56. Shenker, A.; Maayani, S.; Weinstein, H.; Green, J. P. Pharmacological characterization of two 5-hydroxytryptamine receptors coupled to adenylate cyclase in guinea pig hippocampal membranes. Mol. Pharmacol. 31:357-367; 1987.
57. 4 receptors: A microdialysis study in the halothane-anesthetized rat. Soc. Neurosci. Abstr. 21:369; 1995.
58. Sperk, G.; Baldessarini, R. J. Stabilizing effect of sucrose on leakage of cytoplasm from rat brain synaptosomes in saline media. J. Neurochem. 28:1403-1405; 1977.
59. Suchowski, C. S.; Galloway, M. P. Serotonin (5-HT) receptor subtypes involved in the 5-HT facilitation of dopamine (DA) release in the striatum: Microdialysis studies in vivo. Soc. Neurosci. Abstr. 21:369; 1995.
60. Sulzer, D.; Rayport, S. Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: A mechanism of action. Neuron 5:797-808; 1990.
61. Sulzer, D.; Maidment, N. T.; Rayport, S. Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J. Neurochem., 60: 527-535;1993.
62. Teicher M. H. ALLFIT: Conversion of dose-response analysis program of A. DeLean, P.J. Munson and D. Rodbard to the MacIntosh Computer; McLean Hospital: Belmont, MA; unpublished software; 1991.
63. 1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)-tetralin in the rat. Eur. J. Pharmacol. 106:271-282; 1985.
64. 2 receptor mechanisms in the mediation of extrapyramidal motor functions in the rat. Pharmacol. Biochem. Behav. 47:509-513; 1994.
65. Waldmeier, P. C.; Delini-Stula, A. A. Serotonin-dopamine interactions in the nigrostriatal system. Eur. J. Pharmacol. 55:363-373; 1979.
66. 3H]dopamine by serotonin from superfused rat striatal slices. Neurosci. Lett. 28:205-209; 1982.
67. Yadid, G.; Pacak, K.; Kopin, I. J.; Goldstein, D. S. Endogenous serotonin stimulates striatal dopamine release in conscious rats. J. Pharmacol. Exp. Ther. 270:1158-1165; 1994.
68. Yeghiayan, S. K.; Kelley, A. E. Orofacial stereotypy induced by serotonergic stimulation of the ventrolateral striatum is dependent on presynaptic dopamine release. Soc. Neurosci. Abstr. 19:594; 1993.
69. Yeghiayan, S. K.; Kelley, A. E. Serotonergic stimulation of the ventrolateral striatum induces orofacial stereotypy. Pharmacol. Biochem. Behav. 52:493-501; 1995.
70. 3H] dopamine release from rat striatal synaptosomes. Eur. J. Pharmacol. 199:185-189; 1991.
71. Young, K. A.; Zavodny, R.; Hicks, P. B. Effects of serotonergic agents on apomorphine-induced locomotor activity. Psychopharmacology 110:97-102; 1993.